Shruti Chaudhary

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh et al. · Leukemia · 2021 · 101 citations · Full text

Medicine, Hematology, Oncology +15

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemia

Nikhil Patkar, Rohan Kodgule, Chinmayee Kakirde et al. · Oncotarget · 2018 · 36 citations · Full text

Medicine, Hematology, Oncology +17

Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Ajay Kumar Chaudhary, Shruti Chaudhary, Kanjaksha Ghosh et al. · Asian Pacific Journal of Cancer Prevention · 2016 · 30 citations · Full text

Medicine, Molecular Biology, Oncology +17

<i>MYD88</i>mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart

Nikhil Patkar, P. G. Subramanian, Prashant Deshpande et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 21 citations

Medicine, Oncology, Pathology +17

Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context

Nikhil Patkar, Chinmayee Kakirde, Prasanna Bhanshe et al. · Frontiers in Oncology · 2019 · 20 citations · Full text

Medicine, Hematology, Oncology +17